CFTR and cystic fibrosis: This short perspective outlines the roles of soluble factors and EVs in modulating immunity in CF, and assesses the potential effects of highly effective CFTR modulator therapy (HEMT, the new standard molecular therapy for CF) on cell–cell communication.